Teva Pharmaceuticals USA, Inc. is recalling 32,740 cartons of Nortrel (norethindrone and ethinyl estradiol) birth control tablets. The recall was initiated because discolored blue tablets were found mixed in with the white inert (reminder) tablets in the blister cards. The affected products include Nortrel 0.5/35 and Nortrel 7/7/7, which were distributed nationwide in the United States.
The presence of discolored blue tablets in the remainder/inert portion of the birth control regimen could lead to consumer confusion. If a user takes the wrong tablet or is confused by the sequence, it may disrupt the intended dosing schedule, though the risk of serious health consequences is low.
You have 2 options:
Rx only
Rx only
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.